Approval · Notice of Compliance 21233 · 2018
APO-ACYCLOVIR OINTMENT: Notice of Compliance 21233
Issued August 20, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21233
- Date
- August 20, 2018
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updates to the labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-ACYCLOVIR OINTMENT | Not yet assigned | — |
Medicinal ingredients
- ACYCLOVIR 5 PER